| ISIN | CH0368915242 |
|---|---|
| Valor Number | 36891524 |
| Bloomberg Global ID | |
| Fund Name | GENERALI Equity Fund Switzerland B |
| Fund Provider |
Generali Investments Schweiz AG
Soodmattenstrasse 2 8134 Adliswil 1 E-Mail: headoffice.ch@generali-invest.com Web: www.generali.ch/investments |
| Fund Provider | Generali Investments Schweiz AG |
| Representative in Switzerland | |
| Distributor(s) |
Generali Holding AG Adliswil Phone: +41 58 472 44 44 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 324.98 CHF | 17.11.2025 |
|---|---|---|
| Previous Price * | 326.02 CHF | 14.11.2025 |
| 52 Week High * | 330.50 CHF | 12.11.2025 |
| 52 Week Low * | 275.56 CHF | 09.04.2025 |
| NAV * | 324.98 CHF | 17.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 55,471,235 | |
| Unit/Share Assets *** | 48,417 | |
| Trading Information SIX | ||
| YTD Performance | +11.24% |
30.12.2024 - 17.11.2025
30.12.2024 17.11.2025 |
|---|---|---|
| 1 month | +0.13% |
17.10.2025 - 17.11.2025
17.10.2025 17.11.2025 |
| 3 months | +2.70% |
18.08.2025 - 17.11.2025
18.08.2025 17.11.2025 |
| 6 months | +1.87% |
19.05.2025 - 17.11.2025
19.05.2025 17.11.2025 |
| 1 year | +11.20% |
18.11.2024 - 17.11.2025
18.11.2024 17.11.2025 |
| 2 years | +22.11% |
17.11.2023 - 17.11.2025
17.11.2023 17.11.2025 |
| 3 years | +22.61% |
17.11.2022 - 17.11.2025
17.11.2022 17.11.2025 |
| 5 years | +32.64% |
17.11.2020 - 17.11.2025
17.11.2020 17.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 12.35% | |
|---|---|---|
| Roche Holding AG | 11.43% | |
| Nestle SA | 11.36% | |
| UBS Group AG Registered Shares | 5.90% | |
| Zurich Insurance Group AG | 5.14% | |
| Compagnie Financiere Richemont SA Class A | 4.58% | |
| ABB Ltd | 4.30% | |
| Lonza Group Ltd | 3.00% | |
| Swiss Re AG | 2.91% | |
| Sandoz Group AG Registered Shares | 2.85% | |
| Last data update | 31.10.2025 | |
| TER | 0.00% |
|---|---|
| TER date | 30.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |